
    
      US multicenter, prospective, single-arm, observational post market Registry. A pilot registry
      towards a subsequent large pivotal registry (PATHFINDER II), aimed to evaluate the safety and
      efficacy of Auryonâ„¢ Atherectomy System in the treatment of de novo, re-stenotic and ISR
      lesions in infra-inguinal arteries of Peripheral Artery Diseases (PAD) subjects, in a
      real-world setting within the initial launch phase of the product in the market.
    
  